FDA.reportPublic FDA data

linagliptin 5 MG Oral Tablet

RxCUI
1100702
RxNorm name
linagliptin 5 MG Oral Tablet
Display name
linagliptin 5 MG Oral Tablet
Full name
linagliptin 5 MG Oral Tablet
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:39:20

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
TradjentaLINAGLIPTINCardinal Health 107, LLCdfe327e8-f6ab-41e5-bdef-d520118cd83a2025-08-27Warnings, Adverse reactionsExact identifier
rxcui: 1100702
TradjentaLINAGLIPTINBoehringer Ingelheim Pharmaceuticals, Inc.c797ea5c-cab7-494b-9044-27eba0cfe40f2025-03-21Warnings, Adverse reactionsExact identifier
rxcui: 1100702
TradjentaLINAGLIPTINA-S Medication Solutionsb1da67d4-51e0-41b7-9fe1-7f38c0d1baa12024-01-22Warnings, Adverse reactionsExact identifier
rxcui: 1100702

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
c797ea5c-cab7-494b-9044-27eba0cfe40flinagliptin 5 MG Oral TabletSCD32These highlights do not include all the information needed to use TRADJENTA safely and effectively. See full prescribing information for TRADJENTA. TRADJENTA ® (linagliptin tablets), for oral use Initial U.S. Approval: 201120250321
c797ea5c-cab7-494b-9044-27eba0cfe40flinagliptin 5 MG Oral TabletPSN32These highlights do not include all the information needed to use TRADJENTA safely and effectively. See full prescribing information for TRADJENTA. TRADJENTA ® (linagliptin tablets), for oral use Initial U.S. Approval: 201120250321
dfe327e8-f6ab-41e5-bdef-d520118cd83alinagliptin 5 MG Oral TabletSCD12These highlights do not include all the information needed to use TRADJENTA safely and effectively. See full prescribing information for TRADJENTA. TRADJENTA ® (linagliptin tablets), for oral use Initial U.S. Approval: 201120250827
dfe327e8-f6ab-41e5-bdef-d520118cd83alinagliptin 5 MG Oral TabletPSN12These highlights do not include all the information needed to use TRADJENTA safely and effectively. See full prescribing information for TRADJENTA. TRADJENTA ® (linagliptin tablets), for oral use Initial U.S. Approval: 201120250827
b1da67d4-51e0-41b7-9fe1-7f38c0d1baa1linagliptin 5 MG Oral TabletPSN8These highlights do not include all the information needed to use TRADJENTA safely and effectively. See full prescribing information for TRADJENTA. TRADJENTA ® (linagliptin tablets), for oral use Initial U.S. Approval: 201120240122
b1da67d4-51e0-41b7-9fe1-7f38c0d1baa1linagliptin 5 MG Oral TabletSCD8These highlights do not include all the information needed to use TRADJENTA safely and effectively. See full prescribing information for TRADJENTA. TRADJENTA ® (linagliptin tablets), for oral use Initial U.S. Approval: 201120240122
cbdbd4b2-c07b-00e1-e053-2995a90a5fc9linagliptin 5 MG Oral TabletSCD6These highlights do not include all the information needed to use LINAGLIPTIN TABLETS safely and effectively. See full prescribing information for LINAGLIPTIN TABLETS. LINAGLIPTIN tablets, for oral use Initial U.S. Approval: 201120260114
cbdbd4b2-c07b-00e1-e053-2995a90a5fc9linagliptin 5 MG Oral TabletPSN6These highlights do not include all the information needed to use LINAGLIPTIN TABLETS safely and effectively. See full prescribing information for LINAGLIPTIN TABLETS. LINAGLIPTIN tablets, for oral use Initial U.S. Approval: 201120260114